The Ministry of Health’s Health System Policy and Oversight (HSPO) division oversees the BC PharmaCare program. HSPO is also responsible for overseeing the provisioning, management and optimal use of pharmaceuticals, and the pharmaceutical-related systems and services that improve client outcomes in the B.C. health system.
Jump to: Complexity | Key capability areas | Strategic areas of focus
The Pharmaceutical Care Management Strategy (PCMS) was developed in 2020 through consultation and collaboration with a broad range of health sector partners. At the time, pharmaceutical care management was the responsibility of the now-renamed Pharmaceutical, Laboratory and Blood Services Division (PLBSD).
This strategy identifies:
Low complexity of infrastructure, capacity, legislation, policy and contracts:
Medium complexity of infrastructure, capacity, legislation, policy and contracts:
High complexity of infrastructure, capacity, legislation, policy and contracts:
Read the Pharmaceutical Care Management Strategy (PDF, 3.64MB) report for full details.

The PCMS focuses on the strengths necessary to deliver on HSPO’s mandate while offering the greatest value to citizens. More than 50 partners who play key roles in pharmaceutical care management across the health sector were engaged to share perspectives on key capabilities, challenges and opportunities to deliver on the mandate. This included representatives from the Ministry of Health, the Provincial Health Services Authority, health authorities, regulatory colleges, research and academic institutions, health associations, health professionals, including family medicine and nursing, and community pharmacists.
These key capability areas were identified:
To meet the needs of clients and populations, the PCMS aims to achieve the best possible patient outcomes from pharmaceutical care in nine strategic areas of focus:
Implementing these strategic areas of focus will produce key shifts across the province:
